SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Kazem Vatankhah Yazdi,1 Seyed Mehdi Kalantar,1 Massoud Houshmand,2,3 Masoud Rahmanian,4 Masoud Reza Manaviat,5 Mohammad Reza Jahani,6 Behnam Kamalidehghan,2,7 Amir Almasi-Hashiani8 1Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 2Department of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR, Kamalidehghan B, Almasi-Hashiani A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	type 2 diabetes mellitus (t2dm) iranian populations the tetra amplification refractory mutation system (arms) the genome-wide association studies (gwas) pharmacogenetics and pharmacogenomic Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/4762a33987e3497b99b9651c77919c14
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4762a33987e3497b99b9651c77919c14
record_format	dspace
spelling	oai:doaj.org-article:4762a33987e3497b99b9651c77919c142021-12-02T08:55:48ZSLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients1178-7007https://doaj.org/article/4762a33987e3497b99b9651c77919c142020-03-01T00:00:00Zhttps://www.dovepress.com/slc30a8-cdkal1-tcf7l2-kcnq1-and-igf2bp2-are-associated-with-type-2-dia-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Kazem Vatankhah Yazdi,1 Seyed Mehdi Kalantar,1 Massoud Houshmand,2,3 Masoud Rahmanian,4 Masoud Reza Manaviat,5 Mohammad Reza Jahani,6 Behnam Kamalidehghan,2,7 Amir Almasi-Hashiani8 1Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 2Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran; 3Research Center, Knowledge University, Erbil, Kurdistan Region, Iraq; 4Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 5Department of Ophthalmology, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 6Taban Health Care and Diabetes Clinic Lab, Tehran, Iran; 7Medical Genetics Department, Jiroft University of Medical Sciences and Health Services, Jiroft, Iran; 8Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, IranCorrespondence: Seyed Mehdi KalantarReproductive & Genetic Unit, Abortion Research Centre Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences and Health Services, Bau Ali Ave. Safaeyeh, Yazd, IranTel +9838247086Fax +9838247087 Email kalantarsm@ystp.ac.irBackground: Type 2 diabetes mellitus (T2DM) is a serious public health issue with significantly increasing rates across the world. The genome-wide association studies (GWAS) have previously manifested involved genes that remarkably enhance the risk of T2DM. In this study, the association of common variants with T2DM risk has been identified among Iranian population from Tehran province of Iran.Methods: Here, the association of refSNPs with T2DM risk was examined on peripheral blood samples of 268 individuals including control group and patients with T2DM using the tetra amplification refractory mutation system (ARMS) methods and direct genomic DNA sequencing.Results: Our study demonstrated that SLC30A8 rs13266634 (T/C), CDKAL1 rs10946398 (A/C), TCF7L2 rs7903146 (C/T), KCNQ1 rs2237892 (T/C), and IGF2BP2 rs1470579 (A/C) polymorphisms are significantly associated with type 2 diabetes, but no significant association was identified for FTO rs8050136 and MTNR1B rs10830963 polymorphisms.Conclusion: The prediction of refSNPs is remarkably needed for pharmacogenetics and pharmacogenomic approaches, in which the information would be useful for clinicians to optimize therapeutic strategies and adverse drug reactions in patients with T2DM.Keywords: type 2 diabetes mellitus, T2DM, Iranian populations, the tetra amplification refractory mutation system, ARMS, the genome-wide association studies, GWASVatankhah Yazdi KKalantar SMHoushmand MRahmanian MManaviat MRJahani MRKamalidehghan BAlmasi-Hashiani ADove Medical Pressarticletype 2 diabetes mellitus (t2dm)iranian populationsthe tetra amplification refractory mutation system (arms)the genome-wide association studies (gwas)pharmacogenetics and pharmacogenomicSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 897-906 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	type 2 diabetes mellitus (t2dm) iranian populations the tetra amplification refractory mutation system (arms) the genome-wide association studies (gwas) pharmacogenetics and pharmacogenomic Specialties of internal medicine RC581-951
spellingShingle	type 2 diabetes mellitus (t2dm) iranian populations the tetra amplification refractory mutation system (arms) the genome-wide association studies (gwas) pharmacogenetics and pharmacogenomic Specialties of internal medicine RC581-951 Vatankhah Yazdi K Kalantar SM Houshmand M Rahmanian M Manaviat MR Jahani MR Kamalidehghan B Almasi-Hashiani A SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
description	Kazem Vatankhah Yazdi,1 Seyed Mehdi Kalantar,1 Massoud Houshmand,2,3 Masoud Rahmanian,4 Masoud Reza Manaviat,5 Mohammad Reza Jahani,6 Behnam Kamalidehghan,2,7 Amir Almasi-Hashiani8 1Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 2Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran; 3Research Center, Knowledge University, Erbil, Kurdistan Region, Iraq; 4Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 5Department of Ophthalmology, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 6Taban Health Care and Diabetes Clinic Lab, Tehran, Iran; 7Medical Genetics Department, Jiroft University of Medical Sciences and Health Services, Jiroft, Iran; 8Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, IranCorrespondence: Seyed Mehdi KalantarReproductive & Genetic Unit, Abortion Research Centre Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences and Health Services, Bau Ali Ave. Safaeyeh, Yazd, IranTel +9838247086Fax +9838247087 Email kalantarsm@ystp.ac.irBackground: Type 2 diabetes mellitus (T2DM) is a serious public health issue with significantly increasing rates across the world. The genome-wide association studies (GWAS) have previously manifested involved genes that remarkably enhance the risk of T2DM. In this study, the association of common variants with T2DM risk has been identified among Iranian population from Tehran province of Iran.Methods: Here, the association of refSNPs with T2DM risk was examined on peripheral blood samples of 268 individuals including control group and patients with T2DM using the tetra amplification refractory mutation system (ARMS) methods and direct genomic DNA sequencing.Results: Our study demonstrated that SLC30A8 rs13266634 (T/C), CDKAL1 rs10946398 (A/C), TCF7L2 rs7903146 (C/T), KCNQ1 rs2237892 (T/C), and IGF2BP2 rs1470579 (A/C) polymorphisms are significantly associated with type 2 diabetes, but no significant association was identified for FTO rs8050136 and MTNR1B rs10830963 polymorphisms.Conclusion: The prediction of refSNPs is remarkably needed for pharmacogenetics and pharmacogenomic approaches, in which the information would be useful for clinicians to optimize therapeutic strategies and adverse drug reactions in patients with T2DM.Keywords: type 2 diabetes mellitus, T2DM, Iranian populations, the tetra amplification refractory mutation system, ARMS, the genome-wide association studies, GWAS
format	article
author	Vatankhah Yazdi K Kalantar SM Houshmand M Rahmanian M Manaviat MR Jahani MR Kamalidehghan B Almasi-Hashiani A
author_facet	Vatankhah Yazdi K Kalantar SM Houshmand M Rahmanian M Manaviat MR Jahani MR Kamalidehghan B Almasi-Hashiani A
author_sort	Vatankhah Yazdi K
title	SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
title_short	SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
title_full	SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
title_fullStr	SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
title_full_unstemmed	SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
title_sort	slc30a8, cdkal1, tcf7l2, kcnq1 and igf2bp2 are associated with type 2 diabetes mellitus in iranian patients
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/4762a33987e3497b99b9651c77919c14
work_keys_str_mv	AT vatankhahyazdik slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT kalantarsm slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT houshmandm slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT rahmanianm slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT manaviatmr slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT jahanimr slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT kamalidehghanb slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients AT almasihashiania slc30a8cdkal1tcf7l2kcnq1andigf2bp2areassociatedwithtype2diabetesmellitusiniranianpatients
_version_	1718398298931331072

SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Ejemplares similares